101 related articles for article (PubMed ID: 9219599)
1. Effect of glimepiride and glibenclamide, inhibitors of ATP-dependent K(+)-channel, on ischaemia-reperfusion induced arrhythmias in rats.
Bozdogan O; Leprán I; Papp JG
Acta Physiol Hung; 1996; 84(3):265-6. PubMed ID: 9219599
[TBL] [Abstract][Full Text] [Related]
2. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
Tawfik MK; Abo-Elmatty DM; Ahmed AA
Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
[TBL] [Abstract][Full Text] [Related]
3. Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
Iskit AB; Erkent U; Ertunc M; Guc MO; Ilhan M; Onur R
Vascul Pharmacol; 2007 Feb; 46(2):129-36. PubMed ID: 17064967
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats.
El-Reyani NE; Bozdogan O; Baczkó I; Leprán I; Papp JG
Eur J Pharmacol; 1999 Jan; 365(2-3):187-92. PubMed ID: 9988102
[TBL] [Abstract][Full Text] [Related]
5. Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels.
Rajesh KG; Sasaguri S; Suzuki R; Xing Y; Maeda H
Int J Cardiol; 2004 Jul; 96(1):41-9. PubMed ID: 15203260
[TBL] [Abstract][Full Text] [Related]
6. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
7. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
Vajda S; Baczkó I; Leprán I
Eur J Pharmacol; 2007 Dec; 577(1-3):115-23. PubMed ID: 17904545
[TBL] [Abstract][Full Text] [Related]
8. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
Johansen D; Ytrehus K; Baxter GF
Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
[TBL] [Abstract][Full Text] [Related]
9. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
Das B; Sarkar C; Karanth KS
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
[TBL] [Abstract][Full Text] [Related]
10. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias.
Picard S; Rouet R; Duval D; Chesnay F; Gérard JL
J Mol Cell Cardiol; 1998 Dec; 30(12):2613-21. PubMed ID: 9990533
[TBL] [Abstract][Full Text] [Related]
11. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury.
Pompermayer K; Amaral FA; Fagundes CT; Vieira AT; Cunha FQ; Teixeira MM; Souza DG
Eur J Pharmacol; 2007 Feb; 556(1-3):215-22. PubMed ID: 17182029
[TBL] [Abstract][Full Text] [Related]
12. Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts.
Maruyama I; Tomiyama Y; Maruyama K; Ojima K; Kobayashi K; Kobayashi M; Yamazaki Y; Kojima M; Shibata N
Eur J Pharmacol; 2006 Feb; 531(1-3):194-200. PubMed ID: 16443212
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Du Toit EF; Muller CA; McCarthy J; Opie LH
J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
[TBL] [Abstract][Full Text] [Related]
14. The protection of resveratrol and its combination with glibenclamide, but not berberine on the diabetic hearts against reperfusion-induced arrhythmias: the role of myocardial K
Kaya ST; Bozdogan O; Ozarslan TO; Taskin E; Eksioglu D; Erim F; Firat T; Yasar S
Arch Physiol Biochem; 2019 May; 125(2):114-121. PubMed ID: 29457517
[TBL] [Abstract][Full Text] [Related]
15. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
16. HMR 1883, a cardioselective K(ATP) channel blocker, inhibits ischaemia- and reperfusion-induced ventricular fibrillation in rats.
Wirth KJ; Klaus E; Englert HG; Schölkens BA; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):295-300. PubMed ID: 10543431
[TBL] [Abstract][Full Text] [Related]
17. The protection by ischemic preconditioning against myocardial ischemia- and reperfusion-induced arrhythmias is not mediated by ATP-sensitive potassium channels in rats.
Lu H; Remeysen P; De Clerck F
Coron Artery Dis; 1993 Jul; 4(7):649-57. PubMed ID: 8281370
[TBL] [Abstract][Full Text] [Related]
18. Concerning the effect of the K+ channel blocking agent glibenclamide on ischaemic and reperfusion arrhythmias.
Bernauer W
Eur J Pharmacol; 1997 May; 326(2-3):147-56. PubMed ID: 9196267
[TBL] [Abstract][Full Text] [Related]
19. Effect of almokalant a specific inhibitor of IKr on myocardial ischaemia-reperfusion induced arrhythmias in rabbits.
Farkas A; Leprán I; Papp JG
Acta Physiol Hung; 1996; 84(3):281-2. PubMed ID: 9219607
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of conventional sulfonylureas and glimepiride.
Geisen K; Végh A; Krause E; Papp JG
Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
